Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMP 013: Tandem Thiotepa Regimen For Selected Malignant Gliomas
NCT00008008Phase 2Completed
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Sep 1997
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in malignant glioma, sponsored by Herbert Irving Comprehensive Cancer Center. Started Sep 1997; status: completed.
02
Drugs
thiotepa
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00008008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008008.